Novastan argatroban small molecule thrombin inhibitor data

TXB announced positive Phase III data from its ARG-911 trial comparing Novastan treatment in 304 patients (160 with HIT

Read the full 193 word article

How to gain access

Continue reading with a
two-week free trial.